NASDAQ: NNNN
Anbio Biotechnology Stock Ownership - Who owns Anbio Biotechnology?

Insider buying vs selling

Have Anbio Biotechnology insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NNNN insiders and whales buy or sell their stock.

NNNN Shareholders

What type of owners hold Anbio Biotechnology stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Geodec0.00%27$103.68Institution
Geode Capital Management LLC0.00%26$99.84Institution
Boacrp0.00%13$49.92Institution
Bank Of America Corp0.00%13$49.92Institution
Bnppar0.00%12$46.08Institution
Marwac0.00%12$46.08Institution
Marshall Wace LLP0.00%11$42.24Institution
Bnp Paribas Financial Markets0.00%11$42.24Institution
Morsta0.00%7$26.88Institution
Morgan Stanley0.00%7$26.88Institution

1 of 3

NNNN vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NNNN0.00%0.00%
ANGO0.09%23.67%Net Selling
AVR0.07%36.65%Net BuyingNet Selling
EMBC0.09%3.96%Net SellingNet Buying
SMTI0.00%100.00%Net SellingNet Selling

Anbio Biotechnology Stock Ownership FAQ

Who owns Anbio Biotechnology?

Anbio Biotechnology (NASDAQ: NNNN) is owned by 0.00% institutional shareholders, 0.00% Anbio Biotechnology insiders, and 100.00% retail investors. Geodec is the largest individual Anbio Biotechnology shareholder, owning 27.00 shares representing 0.00% of the company. Geodec's Anbio Biotechnology shares are currently valued at $100.44.

If you're new to stock investing, here's how to buy Anbio Biotechnology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.